C19-9, non-RGD integrin αvß3 receptor inhibitor, 25mg, CAS# 1477482-47-5
$150.00
N-[(E)-(3-Hydroxy-4-methoxyphenyl)methylideneamino]-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide Purity: >98% by TLC NMR (Conforms) Store -20°C Ship RT (1 per EA )
Manufacturer: Focus Biomolecules
SKU
10-3977-25mg-EA
C19-9, non-RGD integrin αvß3 receptor inhibitor, 25mg, CAS# 1477482-47-5 is available to buy in increments of 1
Product Details
Download Details and SpecificationsC19-9 (1477482-47-5) is a novel non-RGD inhibitor of the integrin αvß3 receptor (KD = 102 nM). It was active against the human prostate carcinoma epithelial cell line 22RV1 (IC50 = 467 nM) and human prostate cancer organoids (IC50 = 652 nM). C19-9 was active in vivo in 22RV1 mouse xenografts and blocked growth in enzalutamide-resistant mouse CRPC xenografts.
CAS Number: 1477482-47-5
Manufacturer Part Number/SKU: 10-3977-25mg-EA
Tags: Focus Biomolecules